Merck Expands Biosafety Testing Laboratory in Singapore to Strengthen Services Across Asia Pacific
- Written by Reporters
- Expansion adds first BioReliance® Cell Line Characterization and GMP Next-GenerationSequencingin Asia Pacific
- Enhanced testing capabilities to deliver speed, sensitivity, and sustainability for biopharma customers in the region
- Supports industry shift to molecular methods and animal-free testing

